Agilent to Provide Service and Support for NimbleGen as Roche Shutters Microarray Business | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies and Roche today announced that Agilent will provide service to NimbleGen microarray customers as Roche shutters that business.

Researchers using NimbleGen microarrays for all applications can transition to Agilent arrays, effective immediately with minimal disruptions, the companies said. Because of the similarities of the two firms' technologies and products, Agilent microarrays can be run on the NimbleGen MS200 Microarray Scanner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.